NGM · Dividend

Entrada Therapeutics, Inc. (TRDA) Dividend

$4.41 NGM: TRDA Market Cap $171.71M

Metric	Value
Dividend Yield	None
Indicated Annual Dividend	—
Payout Ratio	—
FCF Yield	-64.33%
Current Price	$4.41

Dividend Analysis

Entrada Therapeutics, Inc. (TRDA) does not currently pay a dividend, based on the latest available data. Companies that do not pay dividends may use earnings for reinvestment, acquisitions, share buybacks, or debt repayment instead.

Free cash flow yield of -64.33% is below the 0.00% dividend yield, so the dividend is not fully covered by free cash flow at the current price.

Dividend yield against peers

Entrada Therapeutics, Inc. has the lowest dividend yield of the 6 companies compared here.

Company	Yield	P/E	Price
Achieve Life Sciences, Inc. (ACHV)	0.00%	-4.20	$6.49
Allogene Therapeutics, Inc. (ALLO)	0.00%	-2.24	$1.25
Arcturus Therapeutics Holdings Inc. (ARCT)	0.00%	-3.91	$9.84
Atea Pharmaceuticals, Inc. (AVIR)	0.00%	-2.47	$4.04
Capricor Therapeutics, Inc. (CAPR)	0.00%	-3.93	$5.93
Entrada Therapeutics, Inc. (TRDA)	0.00%	-1.36	$4.41